Use of iPS cells to treat spinal cord injuries

Use of iPS cells to treat spinal cord injuries

Keio University professors Hideyuki Okano (L) and Masaya Nakamura, who together lead a project to use iPS cells to treat patients with spinal cord injuries, speak to reporters in Tokyo on Feb. 18, 2019, following the Japanese health ministry's approval of a clinical study of the project. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000150994
  • Registered date
  • 2019/2/18 18:25:46
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2019 Kyodo News
  • Media size
  • 3968 × 2568 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 804.14(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    New coronavirus

    New coronavirus

    University of Tsukuba graduate school professor Shinya Kuno (L) teaches Japanese health minister Katsunobu Kato how to stretch effectively in a demonstration event at his ministry in Tokyo on May 7, 2020, aimed at enhancing people's health. The group led by the professor launched a campaign to prevent people's health from deteriorating as they are asked to stay home amid the coronavirus pandemic. (Kyodo) ==Kyodo
      New coronavirus

      New coronavirus

      Hokkaido University professor Hiroshi Nishiura (L), a member of the Health Ministry's team to prevent cluster infections, speaks in Tokyo on April 15, 2020. The team expects about 420,000 people in Japan to die from the coronavirus until it is completely gone if no countermeasures are taken. (Kyodo) ==Kyodo
        Use of iPS cells to treat spinal cord injuries

        Use of iPS cells to treat spinal cord injuries

        Keio University professors Hideyuki Okano (L) and Masaya Nakamura, who together lead a project to use iPS cells to treat patients with spinal cord injuries, attend a press conference in Tokyo on Feb. 18, 2019, following the Japanese health ministry's approval of a clinical study of the project. (Kyodo) ==Kyodo
          Use of iPS cells to treat spinal cord injuries

          Use of iPS cells to treat spinal cord injuries

          Keio University professor Hideyuki Okano, who leads a project to use iPS cells to treat patients with spinal cord injuries, speaks at a press conference in Tokyo on Feb. 18, 2019, following the Japanese health ministry's approval of a clinical study of the project. (Kyodo) ==Kyodo
            Novartis division head Epstein

            Novartis division head Epstein

            TOKYO, Japan - David Epstein (L), division head at Novartis AG, the Swiss-based pharmaceutical giant, holds talks with Japanese Health, Labor and Welfare Minister Norihisa Tamura (R) at the ministry in Tokyo on Sept. 26, 2013. Tamura summoned Epstein and sharply criticized the firm for triggering a scandal involving Novartis Pharma K.K., the Japanese subsidiary of Novartis AG. The unit allegedly engaged in deceptive advertizing for the blood pressure-lowering drug Diovan by citing a study based on manipulated clinical data.
              Clinical research using iPS cells approved

              Clinical research using iPS cells approved

              TOKYO, Japan - Members of a health ministry panel hold a meeting in Tokyo on June 26, 2013, on whether to approve the world's first clinical research using human induced pluripotent stem cells, known as iPS cells, which can grow into any type of human tissue. The panel approved a clinical research plan by the Riken governmental scientific research institute and the Foundation for Biomedical Research and Innovation to use iPS cells for regenerating retinas.